Otolaryngology · Vol. 2, No. 2 · 2016 · pp. 47–50 · e-ISSN 2470-4059

The Relationship Between Different Types of Streptococci and Pharyngotonsillitis: A Systematic Review

Sydney Correia Leão, Tania Maria de Andrade Rodrigues

Medical Pathology Assistant, Department of Pathology, Federal University of São Paulo, São Paulo, SP, BrazilBrazil
Full Professor, Department of Morphology, Federal University of Sergipe, São Cristóvão, SE, BrazilBrazil

DOI: https://doi.org/10.17140/otloj-2-112 · Published 2016-04-19 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2016 The Author(s)

Abstract

Introduction: Streptococci were initially viewed by Louis Pasteur in 1879. Brown, in 1919, created the first systematized classification of streptococci in α, β and γ. Rebecca Lancefield contributed for knowledge of streptococcal polysaccharides discovering groups and M cell wall protein. Streptococciare gram positive, catalase and oxidase negative. Streptococci related to pathogenesis of acute sore throat are Streptococcus β-hemolytic of the groups A, B, C, F and G. Objective: Our objective was to make a review of the different types of streptococcus that can cause infection in the oropharynx. Review: Streptococcus pyogenes is belonging to the Lancefield grouping. Skin and mucous membranes of humans are the only known reservoir in the nature of streptococcus group A. Streptococcus of Group B (SGB) was originally isolated by Nocard in 1887. The primary habi-tat of these bacteria is the human colon, although it may colonize the oropharynx and espe-cially, the vagina. For this reason, in mid-1960, the SGB has become a major cause of perinatal bacterial infection, including bacteremia and urinary tract infection in pregnant women. Group C is involved in purulent pharyngitis outbreaks. According to Fox et al, Streptococcus angino-sus is the most common isolate β-hemolytic group C in the oropharynx. Streptococcus Group C (SGC) is reported as “pyogenes-like” because it shares important virulence factors such as hemolysins, extracellular enzymes and M proteins as well as the SGA. Conclusion: We conclude that it’s important to have knowledge about the different types of streptococci to better treat patients with sore throats and problems associated with this condition

Introduction

Streptococci were initially viewed by Louis Pasteur in 1879. He had observed under the microscope “some chain account”, which in 1884 was named Streptococcus by Rosenbach. Brown, in 1919, created the first systematized classification of streptococci in α, β and γ, from standard hemolysis checked on blood agar plates. Colonies of streptococci that produce a clear halo around due to complete lysis of erythrocytes were called β-hemolytic. Strains of streptococci that produce partial hemolysis give a greenish aspect, bright; around the colony are the α-hemolytic. Colonies that are not capable of producing hemolysis are identified as γ or nonhemolytic and rarely cause infection in man.

cell wall composition is similar to other Gram-positive bacteria, although richer in peptidogly-

covering groups and M cell wall protein whose antigenic molecules are considered to become

the basis for grouping these micro-organisms.2,3 The antigens detected in the group of Lancefield consisting of cell wall polysaccharides (groups A, B, C, F and G in humans), and cell wall lipoteichoic acids (group D enterococci). Other Streptococcus, such as viridans group, have no cell wall antigen, and cannot be included in any of these groups.4

Streptococci related to pathogenesis of acute sore throat are Streptococcus β-hemolytic of the groups A, B, C, F and G. In bacterial pharyngotonsillitis (PT), the main single agent is Streptococcus pyogenes, although in the last 50 years, an increased number of human infections caused by β-hemolytic Streptococcus in groups B, C, and G, have been observed worldwide.

Objective

Our goal was to make a review of the different types of streptococcus that can cause infection in the oropharynx.

Review

Streptococcus pyogenes (SGA)

Streptococcus pyogenes is belonging to the Lancefield grouping. Skin and mucous membranes of humans are the only known reservoir in the nature of streptococcus group A. Its pathogenicity is associated with at least two surface molecules, conferring resistance factor: The M protein and the capsular hyaluronic acid.1

The M protein is a flexible and fibrillar structure situated on the surface of the bacterial cell wall, which provides resistance and anti-phagocytic polymorphonuclear leukocytes protective against. Molecularly, they are dimeric and designed in a carboxyl-terminal portion. In their amino-terminal hypervariable portion is the specific nature of their serotype. Currently, there are about 170 types of M protein, found in ´´emm`` patterns 7-9 with more than 750 subtypes.7-9

The capsule is another antiphagocytic hialuronic structure, offering a protection, interfering in the setting of phagocytes. There are other so-called virulence factors such as the opacity factor, hemolysin, streptolysins, streptococcal pyrogenic exotoxin, C5a peptidase and deoxyribonuclease, all with specific 4,10 activities of antigenic protection.4,10

Streptococcus agalactiae (SGB)

β-hemolytic streptococcus or streptococcus of group B (SGB) was originally isolated by Nocard in 1887 and described as the causative agent of bovine mastitis. They are encapsulated microorganisms, diplococcus gram-positive β-hemolytic on blood agar, with most of its strains resistant to bacitracin. Differentiation among the other Lancefield groups is given by capsular polysaccharides and specific antigenic proteins. They include serotypes Ia, Ib, Ia/c, II, III, IV, V, VI, VII and VIII. The SGB produces many virulence factors, including hemolysins, encap-

2,3 sulated polysaccharides, C5a peptidase (only in human pathogenic strains) and some strains produce hyaluronidase and various surface proteins which stimulates the secretion of IgA and act as adhesins.11

The primary habitat of this bacterium is the human colon, although it may colonize the oropharynx and especially, the vagina. For this reason, in mid-1960, the SGB has become a major cause of perinatal bacterial infection, including bacteremia, amniotites, endometritis and urinary tract infection in pregnant women, as well as focal or systemic infections in newborns. The SGB also cause infections in nonpregnant adults including men- 5,6 12,13 ingitis, endocarditis and septic arthritis.

The PT by SGB is reported, mostly in young adults and adults with any immunosuppressive underlying disease. There were no reports of acute SGB pharyngotonsillitis in children of school age.

Streptococcus anginosus (SGC)

Group C is involved in purulent pharyngitis outbreaks. According to Fox et al, Streptococcus anginosus is the most common isolate β-hemolytic group C in the oropharynx, while the Streptococcus equisimilis has been associated with PT. Turner et al14 reported that Streptococcus equisimilis showed strong evidence of being causative agent in patients with PT as Streptococcus anginosus appears to be part of the microbiota of the oropharynx. Al-Charrakh et al15 in their study of the prevalence of Streptococcus β-hemolytic groups C and F in patients with acute pharyngitis, report that these groups are involved in acute PT at 6.2% of cases. Detected yet, many of these isolates showed ability to produce more than a virulence factor. According Zaoutis et al16, Group C Streptococcus (SGC) and Group G Streptococci (SGG) are reported as “pyogenes-like” because they share important virulence factors such as hemolysins, extracellular enzymes and M proteins as well as the SGA.

Regarding the similarity between the SGC and the SGA, Shah et al17 reported that although the β-hemolytic group C is not a common cause of acute PT, comprises similar characteristics to Group A Streptococcus, as both cause isolated exudative, PT and the like cellulitis, making them clinically indistinguishable.

Strains of Streptococcus Group C contains fibrinolysin and streptolysin, such as streptolysin O (ASO). Given this proven by Johnson et al18 who demonstrated in their studies that the group C Streptococcus showed a strong immune response via high titer antibody against ASO (ASO), and that this increase concomitantly persisted in the presence of streptococcus in the oropharynx of the patient.

Although the microbiological characteristics and similar virulence between the GSC and EMS, compared to nonsuppurative complications, Killian11 reports that the GSC may is

Peritonsillar and retropharyngeal abscess

Table 1
Table 1. Some complications of acute PT.

Table 2. Treatment for acute pharyngotonsillitis.

The major criteria for diagnosis includes

Arthritis in several joints (polyarthritis)

Heart inflammation (carditis)

Nodules under the skin (subcutaneous nodules

Rapid, jerky movements (Sydenham’s chorea)

Skin rash (erythemamarginatum)

Table 3. The Jones criteria for diagnosis of rheumatic fever.

related to acute glomerulonephritis but not with the FR. This fact contradicted a study by Haidan et al19, who searched PT by SGC and SGG an aboriginal population, which reported that there was a high incidence of rheumatic fever versus low incidence of SGA infection, leading them to investigate the correlation of a group non-A, FR, suggesting in that results in vitro, the SGC and SGG in those conditions have the potential for initiating an autoimmune response, triggering acute rheumatic fever.

Systemic Effects

Streptococcal PT, if not adequately addressed, can lead to nonsuppurative complications such as rheumatic fever and glomeru- 1,4 lonephritis (Tables 1 and 2).1,4

Rheumatic Fever (RF) is a rheumatic and inflammatory disease, consequence of an untreated upper airway infection for β-hemolytic streptococcus of group A, usually with immunological basis. It is a disease with significant prevalence in the population of school age, manifested as polyarthritis, carditis, chorea, erythema marginatum and/or subcutaneous nodules and is considered the leading cause of chronic valvular heart disease in young adults in developing countries.9 The Jones Criteria guides doctors to clinically diagnose of Rheumatic fever (Table 3). According to American Heart Association (AHA), two major criteria, or one major and two minor criteria plus a previous his-

Complications of acute pharyngotonsillitis Suppurative Non-suppurative

Rheumatic fever Sinusitis Post-streptococci glomerulonephritis Scarlet fever

Drug Dosage

Amoxicillin 500 mg, 3x each day, for 10 days Amoxicillin/Clavulanate 500+125 mg, 3x each day, for 10 days Benzathine penicillin G 1.200.000UI, IM, one dose Erythromycin 250 mg, 4x each day, for 10 days Clindamycin 300 mg, 4x each day, for 10 days

The minor criteria includes

Fever High ESR (erythrocyte sedimentation rate, an laboratory sign of inflammation)

Joint pain (arthralgia) or Aschoff bodies) EKG changes (electrocardiogram) Other laboratory findings (elevated c-reactive protein, elevated or rising streptococcal antigen test)

tory of sore throat infection are necessary to diagnosis.20

The M protein is intrinsically linked to the development of rheumatic fever, which postulated involves molecular mimicry between proteins of the host and streptococcus, where the host antibodies against streptococcal antigens, do not recognize their own structures, converging in the humoral and cellular cross-recognition. This phenomenon occurs between the M protein and myosin in cardiac tissue, resulting in aggression and cell damage.

Conclusion

It is important to have knowledge about the different types of streptococci to better treat patients with sore throats and problems associated with this condition.

CONFLICTS OF INTEREST: None.

References

  1. KonemanEWAllenSDJandaWMSchreckenbergerPCWinnWC. Diagnóstico Microbiológico [In Portugese]. 5ª edi- ção. Rio de Janeiro, Brazil: MEDSI Editora Médica e Científica Ltda; 2001. dos Santos VP. Estreptococcias: Streptococcal infections [In Portugese and English]. Jornal de Pediatria. 1999; 75: Supl 1. Web site. http://www.jped.com.br/conteudo/99-75-S103/port. pdf. Accessed March 10, 2016
  2. EfstratiouA. Group A streptococci in the 1990s. J Antimicrob Chemother. 2000; 45(suppl 1): 3-12. doi: 10.1093/jac/45. suppl_1.310.1093/jac/45.suppl_1.3 https://doi.org/10.1093/jac/45.suppl_1.3
  3. Schaechter M, Engleberg NC, Eisenstein B, E Medoff G. Microbiologia: Mecanismo das Doenças Infecciosas [In Portugese]. 3º edição. Rio de Janeiro, Brazil: Editora: Guanabara Koogan; 2009
  4. Sih TM, Chinski A, Eavy R, Godinho, R. VI Manual de Otorrinolaringologia Pediátrica da IAPO [In Portugese]. São Paulo, Brazil: Gráfica e Editora RR Donneley Ltda; 2007: 265
  5. SitkiewiczIHryniewiczW. Pyogenic streptococci--danger of re-emerging pathogens. Pol J Microbiol. 2010; 59(4): 219-226. Web site. http://www.pjm.microbiology.pl/archive/ vol5942010219.pdf. Accessed March 10, 2016
  6. Smeesters PR, Vergison A, Campos D, de Aguiar E, Miendje Deyi VY, Van Melderen L. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape. PLoS One. 2006; 1(1): e10. doi: 10.1371/journal.pone.0000010 https://doi.org/10.1371/journal.pone.0000010
  7. NochangJ. Variabilidade Genética De Isolados De Streptococcus Pyogenes Por Meio De Marcadores RAPD [In Portugese] [masters thesis]. Curitiba–PR, Brazil: Universidade Federal do Paraná; 2006. Web site. http://dspace.c3sl.ufpr.br/dspace/ bitstream/handle/1884/29830/R%20-%20D%20-%20JULIA-NA%20NOSCHANG.pdf?sequence=1. Accessed March 10, 2016
  8. ScheibelIM. Avaliação da adesão à profilaxia secundária da febre reumática [In Portugese]. Rev Bras Reumatol. 2001; 41(4): 220-224
  9. GuilhermeLCuryPDemarchiLMF. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004; 165(5): 1583-1591. doi: 10.1016/S0002-9440(10)63415-310.1016/s0002-9440(10)63415-3 https://doi.org/10.1016/s0002-9440(10)63415-3
  10. KillianM. Streptococcus and Enterococcus: Pharyngitis; scarlet fever; skin and soft tissue infections; streptococcal toxic shock syndrome; pneumonia; meningitis; urinary tract infections; rheumatic fever; post-streptococcal glomerulonephritis. In: Greenwood D, Barer M, Slack R, Irving W, eds. Medical Microbiology: A Guide to Microbial Infections: Pathogenesis, th immunity, laboratory diagnosis, and control. 16tha ed. London, UK: Churchill Livingstone Elsevier; 2002
  11. Corrado ML, Palmadessa DJ, CorradoSH, Weissman C, Cherubin CE, Landesman SH. Group B streptococcal pharyngitis in the compromised adult: therapeutic considerations. J Natl Med Assoc. 1981; 73(10): 943-947
  12. GotoffSP. Group B streptococcal infections. Pediatr Rev. 2002; 23:381-386
  13. TurnerJCFoxAFoxK. Role of group C beta-hemolytic streptococci in pharyngitis: epidemiologic study of clinical features associated with isolation of group C streptococci. J Clin Microbiol. 1993; 31(4): 808-811. Web site. http://jcm.asm.org/ content/31/4/808.long. Accessed March 10, 2016
  14. Al-CharrakhAAl-KhafajiJKTAl-RubayeRHS. Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis. N Am J Med Sci; 2011; 3(3): 129-136. doi: 10.4297/najms.2011.312910.4297/najms.2011.3129 https://doi.org/10.4297/najms.2011.3129
  15. ZaoutisTAttiaMGrossRKleinJ. The role of group C and group G streptococci in acute pharyngitis in children. Clin Microbiol Infect. 2004; 10: 37-40. doi: 10.1111/j.1469- 0691.2004.00732.x10.1111/j.1469-0691.2004.00732.x https://doi.org/10.1111/j.1469-0691.2004.00732.x
  16. ShahMCentorRMJenningsM. Severe acute pharyngitis caused by group c streptococcus. J Gen Intern Med. 2007; 22(2): 272-274. doi: 10.1007/s11606-006-0049-410.1007/s11606-006-0049-4 https://doi.org/10.1007/s11606-006-0049-4
  17. JohnsonDRKurlanRLeckmanJKaplanEL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis. 2010; 50(4): 481-490. doi: 10.1086/65016710.1086/650167 https://doi.org/10.1086/650167
  18. HaidanATalaySRRohdeMSriprakashKSCurrieBJChhatwalGS. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet. 2000; 356(9236): 1167-1169. doi: 10.1016/S0140- 6736(00)02765-310.1016/s0140-6736(00)02765-3 https://doi.org/10.1016/s0140-6736(00)02765-3
  19. GewitzMHBaltimoreRSTaniLY. Revision of the jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015; 131(20): 1806- 1818. doi: 10.1161/CIR.000000000000020510.1161/cir.0000000000000205 https://doi.org/10.1161/cir.0000000000000205